AIMS: To undertake a multicentre evaluation of translation of a partnered pharmacist medication charting (PPMC) model in patients admitted to general medical units in public hospitals in the state of Victoria, Australia. METHODS: Unblinded, prospective cohort study comparing patients before and after the intervention. Conducted in seven public hospitals in Victoria, Australia from 20 June 2016 to 30 June 2017. Patients admitted to general medical units were included in the study. Medication charting by pharmacists using a partnered pharmacist model was compared to traditional medication charting. The primary outcome variable was the length of inpatient hospital stay. Secondary outcome measures were medication errors detected within 24 h of the patients' admission, identified by an independent pharmacist assessor. RESULTS: A total of 8648 patients were included in the study. Patients who had PPMC had reduced median length of inpatient hospital stay from 4.7 (interquartile range 2.8-8.2) days to 4.2 (interquartile range 2.3-7.5) days (P < 0.001). PPMC was associated with a reduction in the proportion of patients with at least 1 medication error from 66% to 3.6% with a number needed to treat to prevent 1 error of 1.6 (95% confidence interval: 1.57-1.64). CONCLUSION: Expansion of the partnered pharmacist charting model across multiple organisations was effective and feasible and is recommended for adoption by health services.
AIMS: To undertake a multicentre evaluation of translation of a partnered pharmacist medication charting (PPMC) model in patients admitted to general medical units in public hospitals in the state of Victoria, Australia. METHODS: Unblinded, prospective cohort study comparing patients before and after the intervention. Conducted in seven public hospitals in Victoria, Australia from 20 June 2016 to 30 June 2017. Patients admitted to general medical units were included in the study. Medication charting by pharmacists using a partnered pharmacist model was compared to traditional medication charting. The primary outcome variable was the length of inpatient hospital stay. Secondary outcome measures were medication errors detected within 24 h of the patients' admission, identified by an independent pharmacist assessor. RESULTS: A total of 8648 patients were included in the study. Patients who had PPMC had reduced median length of inpatient hospital stay from 4.7 (interquartile range 2.8-8.2) days to 4.2 (interquartile range 2.3-7.5) days (P < 0.001). PPMC was associated with a reduction in the proportion of patients with at least 1 medication error from 66% to 3.6% with a number needed to treat to prevent 1 error of 1.6 (95% confidence interval: 1.57-1.64). CONCLUSION: Expansion of the partnered pharmacist charting model across multiple organisations was effective and feasible and is recommended for adoption by health services.
Authors: Mitchell S Buckley; Lisa M Harinstein; Kimberly B Clark; Pamela L Smithburger; Doug J Eckhardt; Earnest Alexander; Sandeep Devabhakthuni; Craig A Westley; Butch David; Sandra L Kane-Gill Journal: Ann Pharmacother Date: 2013-10-15 Impact factor: 3.154
Authors: E Y Tong; C Roman; B Mitra; G Yip; H Gibbs; H Newnham; D P Smit; K Galbraith; M J Dooley Journal: J Clin Pharm Ther Date: 2016-06-02 Impact factor: 2.512
Authors: Lorna Barton; Judith Futtermenger; Yash Gaddi; Angela Kang; Jon Rivers; David Spriggs; Paul F Jenkins; Campbell H Thompson; Josephine S Thomas Journal: Clin Med (Lond) Date: 2012-04 Impact factor: 2.659
Authors: Corinne M Hohl; Nilu Partovi; Isabella Ghement; Maeve E Wickham; Kimberlyn McGrail; Lisa N Reddekopp; Boris Sobolev Journal: PLoS One Date: 2017-02-13 Impact factor: 3.240
Authors: Hannah Beks; Kevin Mc Namara; Elizabeth Manias; Andrew Dalton; Erica Tong; Michael Dooley Journal: BMC Health Serv Res Date: 2021-03-19 Impact factor: 2.655